C21 Investments Inc. SEC filings CWLXF
C21 Investments Inc. has 310 filings in SEC EDGAR's recent list, going back to Jun 27, 2002. Its latest annual report, Form 20-F, was filed on Jun 12, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Aug 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Form s-8 pos | Aug 26, 2026 | — |
| S-8 POS | Form s-8 pos | Aug 26, 2026 | — |
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Aug 26, 2021 | — |
| F-X | Form f-x | Aug 24, 2018 | — |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CWLXF (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 831609
- Former names
- CURLEW LAKE RESOURCES INC (until Nov 29, 2012); CURLEW LAKE RESOURCES INC /FI (until Jan 3, 2007)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.